Breaking News

CPhI Experts Predict CDMO Mega-mergers and Chinese Patented Products

HPAPI growth driven by virtual and mid-sized pharma, with biosimilars expanding rapidly in Europe

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

CPhI Worldwide has released the findings of part two of the 2016 CPhI Annual Report, which focuses on the immediate and short-term trends in pharmaceutical outsourcing.  Four experts—Gil Roth, Vivek Sharma, Minzhang Chen and Ravi Limaye—examine the implications on growth prospects and drag factors across the EU, China, India and the U.S. The overall findings reveal that recent outsourcing trends are now accelerating, with acquisitions of not only larger contract manufacturers adding specialis...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters